These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26871405)

  • 1. Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.
    Baladi MG; Nielsen SM; McIntosh JM; Hanson GR; Fleckenstein AE
    Behav Pharmacol; 2016 Aug; 27(5):422-30. PubMed ID: 26871405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.
    Marks MJ; Grady SR; Salminen O; Paley MA; Wageman CR; McIntosh JM; Whiteaker P
    J Neurochem; 2014 Jul; 130(2):185-98. PubMed ID: 24661093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.
    Vieira-Brock PL; McFadden LM; Nielsen SM; Ellis JD; Walters ET; Stout KA; McIntosh JM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2015 Dec; 355(3):463-72. PubMed ID: 26391161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.
    Vieira-Brock PL; McFadden LM; Nielsen SM; Smith MD; Hanson GR; Fleckenstein AE
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26164716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.
    Perez XA; McIntosh JM; Quik M
    J Neurochem; 2013 Dec; 127(6):762-71. PubMed ID: 23992036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.
    Ryan RE; Ross SA; Drago J; Loiacono RE
    Br J Pharmacol; 2001 Apr; 132(8):1650-6. PubMed ID: 11309235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
    Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
    Sandager-Nielsen K; Ahring PK; Klein J; van Hout M; Thaneshwaran S; Dos Santos AB; Jacobsen TA; Amrutkar DV; Peters D; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113786. PubMed ID: 31887288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
    Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
    Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.
    McGranahan TM; Patzlaff NE; Grady SR; Heinemann SF; Booker TK
    J Neurosci; 2011 Jul; 31(30):10891-902. PubMed ID: 21795541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
    O'Leary K; Parameswaran N; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.
    Pubill D; Garcia-Ratés S; Camarasa J; Escubedo E
    Neurotoxicology; 2013 Mar; 35():41-9. PubMed ID: 23261423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice.
    Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
    Moretti M; Mugnaini M; Tessari M; Zoli M; Gaimarri A; Manfredi I; Pistillo F; Clementi F; Gotti C
    Mol Pharmacol; 2010 Aug; 78(2):287-96. PubMed ID: 20439469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.
    Perez XA; Bordia T; McIntosh JM; Quik M
    Mol Pharmacol; 2010 Nov; 78(5):971-80. PubMed ID: 20732972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.